Oncology News & Articles

1 Lenalidomide after stem-cell transplantation for multiple myeloma New England Journal of Medicine, May 16, 2012    Clinical Article

2 Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial The Lancet Oncology - Online First, May 16, 2012

3 GDC-0941, a novel class I selective PI3K inhibitor, enhances the efficacy of docetaxel in human breast cancer models by increasing cell death in vitro and in vivo Clinical Cancer Research, May 16, 2012

4 Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites Cancer Causes and Control, May 16, 2012

5 Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study Cancer Causes and Control, May 16, 2012

6 Targeted inhibition of Src kinase with dasatinib blocks thyroid cancer growth and metastasis Clinical Cancer Research, May 16, 2012

7 Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes Full Text BMC Cancer, May 16, 2012    Clinical Article

8 Medical conditions and risk of adult myeloid leukemia Cancer Causes and Control, May 16, 2012

9 Beta blocker use and colorectal cancer risk Cancer, May 16, 2012    Clinical Article

10 Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer Medical Oncology, May 16, 2012    Clinical Article

11 Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma American Journal of Hematology, May 16, 2012

12 Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-up American Journal of Hematology, May 16, 2012

13 The relationship of postoperative complications with in-hospital outcomes and costs after renal surgery for kidney cancer BJU International, May 16, 2012

14 Therapy management of cardiovascular adverse events in the context of targeted therapy for metastatic renal cell carcinoma International Journal of Urology, May 16, 2012

15 Prevalence of primary immune thrombocytopenia in oklahoma American Journal of Hematology, May 16, 2012

16 Long-term follow-up of reduced-intensity allogeneic hematopoietic stem cell transplantation for refractory or relapsed follicular lymphoma American Journal of Hematology, May 16, 2012

17 Analysing transformation of myelodysplastic syndrome to secondary acute myeloid leukemia using a large patient database American Journal of Hematology, May 16, 2012

18 The Influence of Testosterone Suppression and Recovery on Sexual Function in Men With Prostate Cancer: Observations From a Prospective Study in Men Undergoing Intermittent Androgen Suppression The Journal of Urology, May 16, 2012    Clinical Article

19 Accuracy of Primary Systematic Template Guided Transperineal Biopsy of the Prostate for Locating Prostate Cancer: A Comparison With Radical Prostatectomy Specimens The Journal of Urology, May 16, 2012    Clinical Article

20 Biochemical control of prostate cancer with iodine-125 brachytherapy alone Clinical and Translational Oncology, May 16, 2012    Clinical Article

Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies Journal of Thoracic Disease, 08/05/2011

1 Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP Protocol B-24 Journal of Clinical Oncology, April 9, 2012

2 The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal Journal of Gastrointestinal Oncology, April 16, 2012    Free full text

3 Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: Results of the randomized phase III CHER-LB study Journal of Clinical Oncology, April 12, 2012

4 Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer European Journal of Cancer, April 2, 2012

5 Metformin use is associated with better survival of diabetic patients with pancreatic cancer Clinical Cancer Research, April 4, 2012

6 Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study The Lancet, April 24, 2012

7 Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials The Lancet Oncology - Online First, March 22, 2012

8 Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data Journal of Clinical Oncology, April 5, 2012

9 Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer Cancer, April 6, 2012

10 Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial The Lancet Oncology - Online First, March 28, 2012

11 Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial The Lancet - Early Online Publication, April 5, 2012

12 The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus International Journal of Cancer, April 26, 2012

13 Infectious complications of chemotherapy in clinically aggressive mature B and T cell lymphomas European Journal of Internal Medicine , April 3, 2012

14 Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer JAMA, April 19, 2012

15 Association between tamoxifen treatment and diabetes Cancer, April 16, 2012

16 The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer International Journal of Cancer, April 23, 2012

17 Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome European Journal of Cancer, April 11, 2012

18 Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix International Journal of Cancer, April 18, 2012

19 Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial The Lancet Oncology - Online First, April 20, 2012

20 Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C) Journal of Clinical Oncology, April 9, 2012